Integra LifeSciences Holdings Corporation (IART)
USD 22.16
(-3.78%)
USD 22.16
(-3.78%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.68 Billion USD | 4.11% |
| 2022 | 1.61 Billion USD | -2.18% |
| 2021 | 1.65 Billion USD | -0.25% |
| 2020 | 1.65 Billion USD | 13.55% |
| 2019 | 1.45 Billion USD | 7.65% |
| 2018 | 1.35 Billion USD | -26.45% |
| 2017 | 1.84 Billion USD | 176.86% |
| 2016 | 665 Million USD | -6.99% |
| 2015 | 714.97 Million USD | 13.49% |
| 2014 | 629.99 Million USD | 60.69% |
| 2013 | 392.05 Million USD | -24.54% |
| 2012 | 519.54 Million USD | -2.39% |
| 2011 | 532.26 Million USD | 31.98% |
| 2010 | 403.28 Million USD | 4.61% |
| 2009 | 385.51 Million USD | -34.66% |
| 2008 | 590 Million USD | 31.12% |
| 2007 | 449.96 Million USD | 104.48% |
| 2006 | 220.05 Million USD | 85.89% |
| 2005 | 118.37 Million USD | -0.44% |
| 2004 | 118.9 Million USD | -0.3% |
| 2003 | 119.25 Million USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 3.57 Million USD | -73.76% |
| 2000 | 13.63 Million USD | 37.68% |
| 1999 | 9.9 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 186.38 Million USD | -88.92% |
| 2024 Q2 | 2 Billion USD | 978.13% |
| 2024 Q3 | 1.34 Billion USD | -1.0% |
| 2023 Q2 | 1.6 Billion USD | 70.4% |
| 2023 Q4 | 1.68 Billion USD | 61.35% |
| 2023 Q1 | 940.84 Million USD | -41.76% |
| 2023 FY | 1.68 Billion USD | 4.11% |
| 2023 Q3 | 1.04 Billion USD | -34.99% |
| 2022 FY | 1.61 Billion USD | -2.18% |
| 2022 Q2 | 1.71 Billion USD | 4.03% |
| 2022 Q1 | 1.64 Billion USD | -0.14% |
| 2022 Q3 | 1.71 Billion USD | -0.06% |
| 2022 Q4 | 1.61 Billion USD | -5.78% |
| 2021 Q3 | 1.65 Billion USD | -0.02% |
| 2021 Q2 | 1.65 Billion USD | -5.56% |
| 2021 FY | 1.65 Billion USD | -0.25% |
| 2021 Q1 | 1.75 Billion USD | 5.73% |
| 2021 Q4 | 1.65 Billion USD | -0.07% |
| 2020 Q2 | 1.66 Billion USD | -1.52% |
| 2020 Q3 | 1.52 Billion USD | -8.14% |
| 2020 Q4 | 1.65 Billion USD | 8.28% |
| 2020 FY | 1.65 Billion USD | 13.55% |
| 2020 Q1 | 1.68 Billion USD | 15.93% |
| 2019 Q1 | 1.36 Billion USD | 0.78% |
| 2019 Q4 | 1.45 Billion USD | -5.2% |
| 2019 FY | 1.45 Billion USD | 7.65% |
| 2019 Q3 | 1.53 Billion USD | 5.35% |
| 2019 Q2 | 1.45 Billion USD | 6.95% |
| 2018 Q3 | 1.43 Billion USD | -3.0% |
| 2018 FY | 1.35 Billion USD | -26.45% |
| 2018 Q4 | 1.35 Billion USD | -5.45% |
| 2018 Q2 | 1.47 Billion USD | -19.41% |
| 2018 Q1 | 1.83 Billion USD | -0.5% |
| 2017 Q1 | 855 Million USD | 28.57% |
| 2017 FY | 1.84 Billion USD | 176.86% |
| 2017 Q4 | 1.84 Billion USD | 57.18% |
| 2017 Q3 | 1.17 Billion USD | 33.11% |
| 2017 Q2 | 880 Million USD | 2.92% |
| 2016 Q1 | 730 Million USD | 2.1% |
| 2016 Q2 | 705.54 Million USD | -3.35% |
| 2016 FY | 665 Million USD | -6.99% |
| 2016 Q3 | 687.74 Million USD | -2.52% |
| 2016 Q4 | 665 Million USD | -3.31% |
| 2015 Q1 | 617.05 Million USD | -2.05% |
| 2015 FY | 714.97 Million USD | 13.49% |
| 2015 Q3 | 729.73 Million USD | 11.56% |
| 2015 Q2 | 654.13 Million USD | 6.01% |
| 2015 Q4 | 714.97 Million USD | -2.02% |
| 2014 Q2 | 630.97 Million USD | 0.31% |
| 2014 Q3 | 622.97 Million USD | -1.27% |
| 2014 Q4 | 629.99 Million USD | 1.13% |
| 2014 Q1 | 629 Million USD | 60.44% |
| 2014 FY | 629.99 Million USD | 60.69% |
| 2013 Q2 | 543.25 Million USD | 4.19% |
| 2013 FY | 392.05 Million USD | -24.54% |
| 2013 Q4 | 392.05 Million USD | -28.08% |
| 2013 Q3 | 545.14 Million USD | 0.35% |
| 2013 Q1 | 521.38 Million USD | 0.35% |
| 2012 Q2 | 515.94 Million USD | -1.34% |
| 2012 Q3 | 517.73 Million USD | 0.35% |
| 2012 Q4 | 519.54 Million USD | 0.35% |
| 2012 FY | 519.54 Million USD | -2.39% |
| 2012 Q1 | 522.97 Million USD | -1.74% |
| 2011 Q1 | 206.25 Million USD | -48.86% |
| 2011 Q2 | 144.37 Million USD | -30.0% |
| 2011 Q3 | 541.6 Million USD | 275.14% |
| 2011 FY | 532.26 Million USD | 31.98% |
| 2011 Q4 | 532.26 Million USD | -1.72% |
| 2010 Q4 | 403.28 Million USD | 7.97% |
| 2010 FY | 403.28 Million USD | 4.61% |
| 2010 Q3 | 373.51 Million USD | 0.43% |
| 2010 Q2 | 371.9 Million USD | -0.24% |
| 2010 Q1 | 372.78 Million USD | -3.3% |
| 2009 Q3 | 401.45 Million USD | -11.99% |
| 2009 Q2 | 456.15 Million USD | -14.14% |
| 2009 FY | 385.51 Million USD | -34.66% |
| 2009 Q4 | 385.51 Million USD | -3.97% |
| 2009 Q1 | 531.3 Million USD | -9.95% |
| 2008 Q3 | 530 Million USD | 17.78% |
| 2008 Q1 | 569.38 Million USD | 26.54% |
| 2008 FY | 590 Million USD | 31.12% |
| 2008 Q2 | 450 Million USD | -20.97% |
| 2008 Q4 | 590 Million USD | 11.32% |
| 2007 Q2 | 449.96 Million USD | 104.53% |
| 2007 FY | 449.96 Million USD | 104.48% |
| 2007 Q4 | 449.96 Million USD | 0.0% |
| 2007 Q3 | 449.96 Million USD | -0.0% |
| 2007 Q1 | 220 Million USD | -0.02% |
| 2006 FY | 220.05 Million USD | 85.89% |
| 2006 Q3 | 207.09 Million USD | 13.72% |
| 2006 Q2 | 182.11 Million USD | 35.73% |
| 2006 Q1 | 134.16 Million USD | 13.34% |
| 2006 Q4 | 220.05 Million USD | 6.26% |
| 2005 Q1 | 118.63 Million USD | -0.23% |
| 2005 FY | 118.37 Million USD | -0.44% |
| 2005 Q4 | 118.37 Million USD | -0.08% |
| 2005 Q3 | 118.46 Million USD | -0.58% |
| 2005 Q2 | 119.15 Million USD | 0.45% |
| 2004 Q1 | 119.74 Million USD | 0.41% |
| 2004 FY | 118.9 Million USD | -0.3% |
| 2004 Q4 | 118.9 Million USD | -0.27% |
| 2004 Q3 | 119.22 Million USD | 0.75% |
| 2004 Q2 | 118.33 Million USD | -1.17% |
| 2003 Q2 | 119.65 Million USD | 14.3% |
| 2003 FY | 119.25 Million USD | 0.0% |
| 2003 Q4 | 119.25 Million USD | -0.55% |
| 2003 Q3 | 119.91 Million USD | 0.22% |
| 2003 Q1 | 104.68 Million USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | -100.0% |
| 2002 Q1 | - USD | -100.0% |
| 2001 FY | 3.57 Million USD | -73.76% |
| 2001 Q1 | 12.27 Million USD | -9.97% |
| 2001 Q2 | 9.7 Million USD | -20.93% |
| 2001 Q4 | 3.57 Million USD | 0.0% |
| 2001 Q3 | - USD | -100.0% |
| 2000 Q3 | 13.62 Million USD | 8.07% |
| 2000 Q1 | 12.25 Million USD | 23.79% |
| 2000 FY | 13.63 Million USD | 37.68% |
| 2000 Q4 | 13.63 Million USD | 0.04% |
| 2000 Q2 | 12.6 Million USD | 2.87% |
| 1999 Q1 | 11 Million USD | 0.0% |
| 1999 Q2 | 10.7 Million USD | -2.73% |
| 1999 FY | 9.9 Million USD | 0.0% |
| 1999 Q3 | 10.3 Million USD | -3.74% |
| 1999 Q4 | 9.9 Million USD | -3.88% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | -210.457% |
| Nemaura Medical Inc. | 20.03 Million USD | -8295.753% |
| NeuroPace, Inc. | 72.39 Million USD | -2222.926% |
| LENSAR, Inc. | 2.3 Million USD | -72731.615% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -105334.608% |
| Apyx Medical Corporation | 38.5 Million USD | -4267.892% |
| Cutera, Inc. | 431.91 Million USD | -289.358% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -10657.257% |
| BioSig Technologies, Inc. | 452 Thousand USD | -371953.54% |
| Talis Biomedical Corporation | 19.66 Million USD | -8450.346% |
| Cerus Corporation | 95.99 Million USD | -1651.77% |
| Axonics, Inc. | 27.61 Million USD | -5989.3% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | -2292.049% |
| Outset Medical, Inc. | 136.18 Million USD | -1134.824% |
| IRIDEX Corporation | 2.74 Million USD | -61141.151% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | -2023.229% |
| TELA Bio, Inc. | 42.78 Million USD | -3831.0% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -455640.379% |
| RxSight, Inc. | 3.01 Million USD | -55732.736% |
| INVO Bioscience, Inc. | 8.68 Million USD | -19266.272% |
| electroCore, Inc. | 626 Thousand USD | -268539.297% |
| Telesis Bio, Inc. | 34.38 Million USD | -4791.454% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -16272.823% |
| Quipt Home Medical Corp. | 98.94 Million USD | -1599.639% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -71521.891% |
| Pulmonx Corporation | 41.42 Million USD | -3959.68% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -10923.809% |
| Dynatronics Corporation | 6.68 Million USD | -25044.951% |
| Modular Medical, Inc. | 1.19 Million USD | -141217.815% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -641763.359% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -123096.536% |
| LivaNova PLC | 640.4 Million USD | -162.597% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -22792.486% |
| InMode Ltd. | 9.01 Million USD | -18550.128% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | -4187.817% |
| Envoy Medical, Inc. | 404 Thousand USD | -416157.921% |
| Bruker Corporation | 1.37 Billion USD | -21.896% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -2950219.298% |
| DexCom, Inc. | 2.59 Billion USD | 35.17% |
| Align Technology, Inc. | 96.96 Million USD | -1634.265% |
| Nexalin Technology, Inc. | 4463.00 USD | -37680428.792% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -5691.514% |
| PAVmed Inc | 48.72 Million USD | -3351.374% |
| Viveve Medical, Inc. | 5.34 Million USD | -31339.185% |
| Movano Inc. | 252 Thousand USD | -667234.127% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -4969.277% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -911875.054% |
| 908 Devices Inc. | 5.94 Million USD | -28187.334% |
| Nexalin Technology, Inc. | 4463.00 USD | -37680428.792% |
| IceCure Medical Ltd | 599 Thousand USD | -280648.247% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | -304.574% |
| Venus Concept Inc. | 79.69 Million USD | -2010.094% |
| Profound Medical Corp. | 7.9 Million USD | -21186.114% |
| enVVeno Medical Corporation | 1.4 Million USD | -119848.787% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -11962.851% |
| Orthofix Medical Inc. | 134.19 Million USD | -1153.126% |
| Surmodics, Inc. | 29.4 Million USD | -5619.034% |
| iCAD, Inc. | 461 Thousand USD | -364690.022% |
| Nuwellis, Inc. | 981 Thousand USD | -171325.28% |
| IRadimed Corporation | 2.04 Million USD | -82212.609% |
| OrthoPediatrics Corp. | 23.76 Million USD | -6977.786% |
| SI-BONE, Inc. | 38.99 Million USD | -4212.89% |
| Semler Scientific, Inc. | 70 Thousand USD | -2402302.857% |
| iRhythm Technologies, Inc. | 129.82 Million USD | -1195.355% |
| Biotricity, Inc. | 23.87 Million USD | -6942.576% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -19929.562% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -178742.219% |
| Cytosorbents Corporation | 18.31 Million USD | -9082.919% |
| Inogen, Inc. | 21.92 Million USD | -7570.857% |
| MaxCyte, Inc. | 18.74 Million USD | -8872.32% |
| ZimVie Inc. | 521.92 Million USD | -222.205% |
| PAVmed Inc. | 48.72 Million USD | -3351.374% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -84131.505% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -84131.505% |
| Sight Sciences, Inc. | 35.41 Million USD | -4648.636% |
| Insulet Corporation | 1.44 Billion USD | -16.074% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -341711.537% |
| Beyond Air, Inc. | 17.83 Million USD | -9328.054% |
| FONAR Corporation | 41.67 Million USD | -3935.146% |
| AxoGen, Inc. | 69.29 Million USD | -2326.95% |
| Bioventus Inc. | 409.47 Million USD | -310.691% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | -3238.327% |
| Inari Medical, Inc. | 32.04 Million USD | -5147.549% |
| InspireMD, Inc. | 1.59 Million USD | -105334.608% |
| UFP Technologies, Inc. | 46.03 Million USD | -3552.892% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -54658.973% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -162171.575% |
| BrainsWay Ltd. | 471 Thousand USD | -356945.011% |
| BIOLASE, Inc. | 17.91 Million USD | -9289.626% |
| Tenon Medical, Inc. | 1.17 Million USD | -143265.899% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -167732.535% |
| CVRx, Inc. | 30.61 Million USD | -5393.359% |
| AdaptHealth Corp. | 2.29 Billion USD | 26.713% |
| Sintx Technologies, Inc. | 4.24 Million USD | -39515.595% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -84194.837% |
| NanoVibronix, Inc. | 5000.00 USD | -33633540.0% |
| Quanterix Corporation | 41.46 Million USD | -3955.764% |
| Acutus Medical, Inc. | 38.47 Million USD | -4270.389% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -56132.882% |
| Varex Imaging Corporation | 469.5 Million USD | -258.186% |
| Vivani Medical, Inc. | 20.69 Million USD | -8025.638% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -71521.891% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -214674.202% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | -80.065% |
| TransMedics Group, Inc. | 515.94 Million USD | -225.941% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -88270.047% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -698052.576% |
| Spectral AI, Inc. | 1.28 Million USD | -130364.081% |
| Hyperfine, Inc. | 185 Thousand USD | -908917.297% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | -774.855% |
| Biomerica, Inc. | 785 Thousand USD | -214127.006% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -374036.953% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -454279.703% |
| Silk Road Medical, Inc | 84.63 Million USD | -1887.029% |